Andon Health Co., Ltd.

SZSE:002432.SZ

34.97 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 3,186.37726,315.3612,397.0982,008.36706.276563.88597.919420.138397.858425.452407.567356.082354.132298.702313.158279.505216.942
Cost of Revenue 1,238.2295,367.195875.549877.505502.937394.942414.893284.355295.563292.619274.701237.331235.935196.93207.698194.961139.022
Gross Profit 1,948.14820,948.1661,521.5481,130.855203.34168.938183.026135.783102.295132.833132.866118.751118.196101.771105.4684.54477.921
Gross Profit Ratio 0.6110.7960.6350.5630.2880.30.3060.3230.2570.3120.3260.3330.3340.3410.3370.3020.359
Reseach & Development Expenses 263.69264.88966.73176.54580.03468.86494.06441.46643.6519.1458.4948.1179.6578.288000
General & Administrative Expenses 207.629520.41598.48566.14868.27554.94360.96850.34132.25727.88714.5537.7687.39913.54141.91132.04620.247
Selling & Marketing Expenses 440.5771,055.742243.466369.907108.45862.05170.57880.33264.13792.94673.31957.20248.46733.73817.50316.85813.797
SG&A 806.2551,576.158341.951436.055176.733116.994131.546130.67396.394120.83387.87264.9755.86647.27959.41448.90434.044
Other Expenses -128.69430.911151.098147.33396.04286.9926.8824.4160.1262.7922.7550.650.3943.9861.009-0.3670.395
Operating Expenses 1,198.6342,271.957559.78659.932352.809282.848349.622268.663232.239215.825148.489126.507108.32683.10659.41448.90434.044
Operating Income 749.51418,311.8691,002.549777.797-149.47-91.922-171.3218.216-153.19620.313-10.7326.07423.98123.39844.21735.93347.112
Operating Income Ratio 0.2350.6960.4180.387-0.212-0.163-0.2870.02-0.3850.048-0.0260.0170.0680.0780.1410.1290.217
Total Other Income Expenses Net 832.51-54.012-2.917-538.044167.851108.9799.086145.503-23.12692.9187.64414.50114.5048.719-0.819-0.0753.631
Income Before Tax 1,582.02318,257.857999.632239.75318.382-4.93-157.5112.622-153.079.927-7.9796.74524.37527.38445.22635.56547.507
Income Before Tax Ratio 0.4960.6940.4170.1190.026-0.009-0.2630.03-0.3850.023-0.020.0190.0690.0920.1440.1270.219
Income Tax Expense 231.1121,773.76365.2292.925-8.678-2.0718.361-1.876-2.3091.5341.383-0.2083.5683.6686.1854.2613.602
Net Income 1,251.60816,030.169908.642242.32927.0612.687-165.86114.498-150.76110.198-9.1686.98320.80723.71639.04131.30443.905
Net Income Ratio 0.3930.6090.3790.1210.0380.022-0.2770.035-0.3790.024-0.0220.020.0590.0790.1250.1120.202
EPS 2.835.1420.560.0630.03-0.380.04-0.410.03-0.020.020.0530.0730.140.110.15
EPS Diluted 2.7734.320.560.0630.03-0.380.04-0.410.03-0.020.020.0530.0730.140.110.15
EBITDA 857.13419,035.6321,106.312840.574-83.46159.974-87.80152.023-118.96248.7310.97716.24930.67732.69749.25836.92344.741
EBITDA Ratio 0.2690.7230.4620.419-0.1180.284-0.1470.124-0.2990.1150.0270.0460.0870.1090.1570.1320.206